Nanfang Hospital, Southern Medical University
646
137
151
112
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
2.2%
14 terminated/withdrawn out of 646 trials
88.9%
+2.4% vs industry average
16%
103 trials in Phase 3/4
3%
3 of 112 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (646)
A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy
Role: lead
A Multicenter, Prospective, Randomized Controlled Study on EUS-Guided Precise Disconnection of Varices Versus Endoscopic Gastric Variceal Glue Injection for the Prevention of Gastric Variceal Bleeding.
Role: lead
hAESCs Prevent Acute Graft-versus-host Disease After Hematopoietic Stem Cell Transplantation
Role: lead
The Role and Regulatory Mechanism of Germinal Center Immune Response in Hepatitis B Virus Infection
Role: lead
A Bidirectional Study of Individualized Postoperative Adjuvant Treatment Decision Model for Locally Advanced Head and Neck Squamous Cell Carcinoma Based on Multimodal Dynamic Data
Role: lead
A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
Role: lead
Butylphthalide for Brain Edema After Endovascular Treatment
Role: lead
Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
Role: lead
Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With Unresectable Locally Advanced or Postoperative Recurrent Esophageal Squamous Cell Carcinoma
Role: lead
PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A Study
Role: lead
Association of Inflammatory Factors With Complications in the Diabetic Population: a Cross-sectional Study
Role: lead
Association of Lifestyle With Complications in the Diabetic Population
Role: lead
HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL).
Role: collaborator
Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive Bleeding
Role: collaborator
The Effect of PPI on Endoscopic Treatment of WON: a Multicenter Randomized Controlled Trial.
Role: collaborator
New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Role: collaborator
Optimizing Early Nutrition Support in Severe Stroke-2
Role: collaborator
PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers
Role: collaborator
Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study
Role: lead
Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC
Role: collaborator